Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

European Research Council grants worth more than €16.3 million have today been awarded to eight University of Oxford researchers for a range of cutting-edge projects.

Oxford skyline

The highly-competitive awards, given to Europe’s most innovative, high-impact academics, have been won by researchers from across the university’s four divisions - representing the highest number of consolidator grants awarded in the UK. These coveted prizes are awarded by the ERC to researchers with between seven and 12 years’ post-doctoral experience, ‘all selected solely based on excellence’, according to Mariya Gabriel, European Commissioner for Innovation, Research, Culture, Education and Youth.

Professor Patrick Grant, Pro-Vice-Chancellor for Research at the University of Oxford said: ‘These ERC awards are a strong endorsement of the quality and adventure of the research proposed by early and mid-career researchers across the University, in diverse subjects including demography, history, zoology, biology and chemistry.’

Oxford’s winners, each awarded research funding of some €2 million, include Dr Alfredo Castello in the Department of Biochemistry. A specialist in researching the role of RNA-binding proteins in virus infection, Dr Castello’s work has uncovered dozens of RBPs, which are crucial for viruses. Millions of people die each year from RNA viruses.  It is critical to understand the interactions that viruses establish with the host cell.

The full story is available on the University of Oxford website

Similar stories

Same genome, different worlds: How a similar brain causes sexually dimorphic behaviours

General Research

A new paper from Department of Physiology, Anatomy & Genetics's Centre for Neural Circuits and Behaviour has shown how males and females are programmed differently in terms of sex.

Oxford University vaccine developer joins day of vaccinations at the Kassam Stadium

Coronavirus COVID-19 General

Today, Andrew Pollard, Professor of Pediatric Infection and Immunity at the University of Oxford, and chief investigator of the trials of the ChAdOx1 nCoV-19 coronavirus vaccine, volunteered his time to help deliver live-saving Covid vaccinations at the newly opened NHS Vaccine Centre at the Kassam Stadium, Oxford.

New form of gift wrap drives male reproductive success

General Research

A study from the Department of Physiology, Anatomy and Genetics (DPAG) has identified a new communication mechanism that ensures the transfer of a complex mix of signals and nutrients required for successful reproduction between males and females.

PRINCIPLE trial finds antibiotics azithromycin and doxycycline not generally effective treatments for COVID-19

Coronavirus COVID-19 General Research

In March 2020, the UK-wide Platform Randomised trial of INterventions against COVID-19 In older people (PRINCIPLE) trial was established as a flexible, platform randomised clinical trial to test a range of potential treatments for COVID-19 that might be suitable for use in the community to help people recover more quickly and prevent the need for hospital admission. The trial is one of three national platform trials for COVID-19 treatments, and complements the RECOVERY and REMAP-CAP trials that focus on hospitalised patients.

Early animal studies yield promising results for new potential COVID-19 vaccine

Coronavirus COVID-19 General Research

Studies carried out in the MRC Human Immunology Unit (MRC HIU) in collaboration with the Pirbright Institute have shown that a new potential vaccine against COVID-19, named RBD-SpyVLP, produces a strong antibody response in mice and pigs, providing vital information for the further development of the vaccine. Although this type of vaccine is not a competitor for the first wave of vaccines, it is hoped that it will be useful as a standalone vaccine or as a booster for individuals primed with a different COVID-19 vaccine.

Just over half of British Indians would take COVID vaccine

Coronavirus COVID-19 General Research

University of Oxford researchers from the Department of Physiology, Anatomy and Genetics (DPAG) and the Department of Psychiatry, in collaboration with The 1928 Institute, have published a major new study on the impact of COVID-19 on the UK’s largest BME population.